Page last updated: 2024-08-18

xanthenes and Hallucination of Body Sensation

xanthenes has been researched along with Hallucination of Body Sensation in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, MH; Chen, HH; Chiang, CC; Chiu, HY; Lee, MY1
Agola, P; Merlis, S; White, L; Wolpert, A; Yaryura-Tobias, JA1
Gross, H; Kaltenbäck, E1
Bertuzzi, F; Dogliani, P; Senini, G1
Ravn, NF1

Trials

1 trial(s) available for xanthenes and Hallucination of Body Sensation

ArticleYear
A clinical evaluation of clopenthixol.
    Current therapeutic research, clinical and experimental, 1970, Volume: 12, Issue:5

    Topics: Adult; Clinical Trials as Topic; Clopenthixol; Female; Hallucinations; Humans; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Tranquilizing Agents; Xanthenes

1970

Other Studies

4 other study(ies) available for xanthenes and Hallucination of Body Sensation

ArticleYear
N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies.
    Neuropharmacology, 2014, Volume: 81

    Topics: Acetylcysteine; Action Potentials; Amino Acids; Amphetamines; Animals; Benzoates; Bicuculline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Early Growth Response Protein 2; Excitatory Amino Acid Antagonists; Free Radical Scavengers; GABA-A Receptor Antagonists; Glycine; Hallucinations; Hallucinogens; Male; Mice; Proto-Oncogene Proteins c-fos; Receptors, Metabotropic Glutamate; Xanthenes

2014
[Clinical treatment of chronic psychoses with flupenthixol-decanoate (Fluanxol-Depot)].
    Wiener klinische Wochenschrift, 1972, Feb-04, Volume: 84, Issue:5

    Topics: Adolescent; Adult; Aged; Chronic Disease; Delayed-Action Preparations; Ethanol; Hallucinations; Humans; Male; Middle Aged; Paranoid Disorders; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenia, Disorganized; Tranquilizing Agents; Xanthenes

1972
Clinical observations on the therapeutic activity of flupentixol in the treatment of chronic schizophrenia.
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:8

    Topics: Adult; Aged; Blood; Body Weight; Chlorpromazine; Chronic Disease; Delusions; Depression, Chemical; Female; Hallucinations; Humans; Hypnotics and Sedatives; Male; Middle Aged; Orphenadrine; Parkinson Disease, Secondary; Piperazines; Psychomotor Disorders; Psychopharmacology; Schizophrenia; Social Behavior; Stimulation, Chemical; Transaminases; Xanthenes

1970
[Nightmares cured with Sordinol].
    Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry, 1968, Volume: 22, Issue:5

    Topics: Adult; Clopenthixol; Dreams; Female; Hallucinations; Humans; Piperazines; Somnambulism; Tranquilizing Agents; Xanthenes

1968